Pharma Program
A summary of Helix BioMedix Drug Discovery and Development Programs focusing on the Company’s initial candidates in the areas of anti-infective, anti-fungal and MRSA fighting peptides based on the innate immune system.
A summary of Helix BioMedix Drug Discovery and Development Programs focusing on the Company’s initial candidates in the areas of anti-infective, anti-fungal and MRSA fighting peptides based on the innate immune system…click to learn more.
We are developing a novel, broad-spectrum, topical anti-infective for the treatment of skin and wound infections and the prevention of Staphylococcus aureus. Our pre-clinical data have shown that our lead molecules are capable of treating Trichophyton infections and hold great promise for multiple dermatological indications…click to learn more.
Our pre-clinical data have shown that our lead molecules are capable of treating Trichophyton infections and hold great promise for multiple dermatological indications…click to learn more.
Acne, rosacea, fungal conditions and MRSA are common problems facing today’s dermatologists…click to learn more.

Product Pipeline

The Helix BioMedix Drug Discovery and Development Programs focus on the Company’s lead candidates in the areas of anti-infective, anti-fungal and anti-inflammatory peptides based on the innate immune system. With an initial focus on peptides for the treatment of acne and MRSA (Methicillin-resistant Staphylococcus aureus), Helix BioMedix has targeted markets with high demand and unmet needs.